Annual EBITDA
-$17.55 M
-$2.56 M-17.07%
June 30, 2024
Summary
- As of February 8, 2025, KZIA annual EBITDA is -$17.55 million, with the most recent change of -$2.56 million (-17.07%) on June 30, 2024.
- During the last 3 years, KZIA annual EBITDA has fallen by -$13.73 million (-359.93%).
- KZIA annual EBITDA is now -1542.83% below its all-time high of -$1.07 million, reached on June 30, 2013.
Performance
KZIA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
N/A
June 30, 2024
Summary
- KZIA quarterly EBITDA is not available.
Performance
KZIA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
N/A
June 30, 2024
Summary
- KZIA TTM EBITDA is not available.
Performance
KZIA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KZIA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.1% | - | - |
| 3 y3 years | -359.9% | - | - |
| 5 y5 years | -167.6% | - | - |
KZIA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -359.9% | at low | ||||
| 5 y | 5-year | -359.9% | at low | ||||
| alltime | all time | -1542.8% | +23.2% |
Kazia Therapeutics Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | -$17.55 M(+17.1%) | - | - |
| Jun 2023 | -$14.99 M(-12.2%) | - | - |
| Jun 2022 | -$17.06 M(+347.2%) | - | - |
| Jun 2021 | -$3.82 M(-52.9%) | - | - |
| Jun 2020 | -$8.11 M(+23.6%) | - | - |
| Jun 2019 | -$6.56 M(-34.9%) | - | - |
| Jun 2018 | -$10.08 M(-26.2%) | - | - |
| Jun 2017 | -$13.65 M(+25.1%) | - | - |
| Jun 2016 | -$10.92 M(+95.8%) | - | - |
| Jun 2015 | -$5.58 M(-3.3%) | - | - |
| Jun 2014 | -$5.77 M(+440.0%) | - | - |
| Jun 2013 | -$1.07 M(-28.5%) | - | - |
| Jun 2012 | -$1.49 M(-71.0%) | - | - |
| Jun 2011 | -$5.16 M(-62.5%) | - | - |
| Jun 2010 | -$13.76 M(-21.5%) | - | - |
| Jun 2009 | -$17.54 M(-23.2%) | - | - |
| Jun 2008 | -$22.84 M(+11.6%) | -$34.19 M(-1167.2%) | -$34.03 M(+0.5%) |
| Mar 2008 | - | $3.20 M(-153.9%) | -$33.86 M(-1.5%) |
| Dec 2007 | - | -$5.94 M(-305.3%) | -$34.38 M(+0.5%) |
| Sep 2007 | - | $2.90 M(-108.5%) | -$34.21 M(+3.2%) |
| Jun 2007 | -$20.47 M(+61.4%) | -$34.01 M(-1370.9%) | -$33.14 M(+57.0%) |
| Mar 2007 | - | $2.68 M(-146.3%) | -$21.12 M(-4.0%) |
| Dec 2006 | - | -$5.77 M(-245.6%) | -$21.99 M(+16.3%) |
| Sep 2006 | - | $3.97 M(-118.0%) | -$18.90 M(-3.5%) |
| Jun 2006 | -$12.68 M | -$21.98 M(-1322.3%) | -$19.58 M(+26.6%) |
| Mar 2006 | - | $1.80 M(-166.9%) | -$15.47 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | - | -$2.69 M(-181.8%) | -$14.90 M(+7.9%) |
| Sep 2005 | - | $3.29 M(-118.4%) | -$13.82 M(+0.9%) |
| Jun 2005 | -$8.47 M(+11.2%) | -$17.86 M(-856.9%) | -$13.70 M(+4.6%) |
| Mar 2005 | - | $2.36 M(-247.5%) | -$13.10 M(+6.2%) |
| Dec 2004 | - | -$1.60 M(-147.0%) | -$12.33 M(+58.4%) |
| Sep 2004 | - | $3.40 M(-119.7%) | -$7.79 M(-8.2%) |
| Jun 2004 | -$7.62 M(+51.2%) | -$17.27 M(-651.7%) | -$8.48 M(+24.0%) |
| Mar 2004 | - | $3.13 M(+6.2%) | -$6.84 M(-3.1%) |
| Dec 2003 | - | $2.95 M(+8.9%) | -$7.06 M(-2.8%) |
| Sep 2003 | - | $2.71 M(-117.3%) | -$7.26 M(-0.3%) |
| Jun 2003 | -$5.04 M(-43.9%) | -$15.62 M(-636.8%) | -$7.29 M(-28.9%) |
| Mar 2003 | - | $2.91 M(+6.2%) | -$10.25 M(-3.5%) |
| Dec 2002 | - | $2.74 M(+2.1%) | -$10.61 M(-2.1%) |
| Sep 2002 | - | $2.69 M(-114.5%) | -$10.85 M(-1.5%) |
| Jun 2002 | -$8.98 M(-60.2%) | -$18.58 M(-830.5%) | -$11.02 M(-70.9%) |
| Mar 2002 | - | $2.54 M(+1.4%) | -$37.90 M(+17.7%) |
| Dec 2001 | - | $2.51 M(-0.3%) | -$32.21 M(+17.0%) |
| Sep 2001 | - | $2.51 M(-105.5%) | -$27.53 M(+24.6%) |
| Jun 2001 | -$22.56 M(+162.9%) | -$45.47 M(-652.3%) | -$22.10 M(+1216.6%) |
| Mar 2001 | - | $8.23 M(+14.5%) | -$1.68 M(-56.3%) |
| Dec 2000 | - | $7.19 M(-9.5%) | -$3.84 M(-27.3%) |
| Sep 2000 | - | $7.95 M(-131.7%) | -$5.28 M(-28.6%) |
| Jun 2000 | -$8.58 M(-18.5%) | -$25.05 M(-512.5%) | -$7.40 M(-141.9%) |
| Mar 2000 | - | $6.07 M(+5.6%) | $17.65 M(+52.4%) |
| Dec 1999 | - | $5.75 M(-1.4%) | $11.58 M(+98.6%) |
| Sep 1999 | - | $5.83 M | $5.83 M |
| Jun 1999 | -$10.52 M | - | - |
FAQ
- What is Kazia Therapeutics Limited annual EBITDA?
- What is the all time high annual EBITDA for Kazia Therapeutics Limited?
- What is Kazia Therapeutics Limited annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for Kazia Therapeutics Limited?
- What is the all time high TTM EBITDA for Kazia Therapeutics Limited?
What is Kazia Therapeutics Limited annual EBITDA?
The current annual EBITDA of KZIA is -$17.55 M
What is the all time high annual EBITDA for Kazia Therapeutics Limited?
Kazia Therapeutics Limited all-time high annual EBITDA is -$1.07 M
What is Kazia Therapeutics Limited annual EBITDA year-on-year change?
Over the past year, KZIA annual EBITDA has changed by -$2.56 M (-17.07%)
What is the all time high quarterly EBITDA for Kazia Therapeutics Limited?
Kazia Therapeutics Limited all-time high quarterly EBITDA is $8.23 M
What is the all time high TTM EBITDA for Kazia Therapeutics Limited?
Kazia Therapeutics Limited all-time high TTM EBITDA is $17.65 M